We are live on
!
Find out more
Cardiff Oncology
CRDF
CRDF
83 hedge funds and large institutions have $34.1M invested in Cardiff Oncology in 2024 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 27 increasing their positions, 23 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
439% more call options, than puts
Call options by funds: $2.19M | Put options by funds: $406K
17% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 23
17% more capital invested
Capital invested by funds: $29.1M → $34.1M (+$5.02M)
1.85% less ownership
Funds ownership: 29.26% → 27.41% (-1.8%)
8% less funds holding
Funds holding: 90 → 83 (-7)
47% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 15
Holders
83
Holders Change
-7
Holders Change %
-7.78%
% of All Funds
1.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
27
Reduced
23
Closed
15
Calls
$2.19M
Puts
$406K
Net Calls
+$1.78M
Net Calls Change
+$156K
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$1.05M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
+$672K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$499K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$358K |
| 5 |
Two Sigma Advisers
New York
|
+$293K |
Top Sellers
| 1 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$2.23M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$368K |
| 3 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$333K |
| 4 |
Millennium Management
New York
|
-$205K |
| 5 |
JF
Jump Financial
Chicago,
Illinois
|
-$191K |
